Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 January 2019 | Story Mamosa Makaya | Photo Xolisa Mnukwa
Nkahiseng
Nkahiseng Ralepeli will join the Rhodes Scholarship cohort of 2019.

Aspiring lawyer and political prodigy, Nkahiseng Ralepeli, will soon join a cohort of Rhodes Scholarship recipients at the University of Oxford in the UK later this year. He completed his LLB at the University of the Free State (UFS) in 2018, and it comes as no surprise that this young achiever has his eyes set on greater heights.

As a student, Nkahiseng was always a cut above the rest, with his involvement in non-governmental organisations such as Corruption Watch and Debate Afrika, where he used debating to not only educate youth in South Africa but to engage various social ills that plague the country in whichever way he could. He represented the UFS at various debating tournaments such as the Pan-African Universities Debating Championships and the World Universities Debating Championships.

“This is something I’ve wanted for an incredibly long time. Receiving this scholarship is so important, and makes me feel that all my efforts and work have been validated. What I’ve learned is that regardless of the situation you’re born into, rich or poor, hard work is rewarded. I hope this experience will help me realise my dreams and career goals, but most importantly I want to have a significant impact in whatever space I find myself in and on the people I encounter,” said Nkahiseng.

As an Abe Bailey Bursary recipient, he is deeply interested in the transformation of African political theory and the establishment of various structures in the development and maintenance of African ‘infant’ democracies and post-civil wars. He later hopes to pursue a career in South African politics. His list of achievements keeps getting longer as he adds to it the Rhodes Scholarship. The UFS is truly proud to have an alumnus of this high calibre.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept